Role of Optical Coherence Tomography in Identifying Retinal Biomarkers in Frontotemporal Dementia A Review

Purpose of Review Frontotemporal dementia (FTD) is often misdiagnosed or recognized late. Clinical heterogeneity and overlap with other dementias impede accurate diagnosis. FTD biomarkers are limited, expensive, and invasive. We present a narrative review of the current literature focused on optical coherence tomography (OCT) to identify retinal biomarkers of dementia, discuss OCT findings in FTD, and explore the implications of an FTD-specific ocular biomarker for research and patient care. Recent Findings Recent studies suggest that outer retinal thinning detected via OCT may function as a novel ocular biomarker of FTD. The degree and rate of inner retinal thinning may correlate with disease severity and progression. In Alzheimer disease (AD), OCT demonstrates thinning of the inner retina, which may differentiate this condition from FTD. We conducted a comprehensive search of the literature and reviewed published OCT findings in FTD, AD, and mild cognitive impairment, as well as reports on biomarkers of FTD and AD used in the research and patient care settings. Three of the authors (O.M., N.S.K., and K.Z.Y.) independently conducted literature searches using PubMed to identify studies published before May 1, 2020, using the following search terminology: Alzheimer's disease, Alzheimer's dementia, frontotemporal dementia, FTD, mild cognitive impairment, dementia biomarkers, and neurodegeneration biomarkers. Search results were then refined using one or more of the following keywords: optical coherence tomography, optical coherence tomography angiography, retinal imaging, and retinal thinning. The selection of published works for inclusion in this narrative review was then limited to full-text articles written in English based on consensus agreement of the authors. Summary FTD diagnosis is imprecise, emphasizing the need for improved state and trait biomarkers. OCT imaging of the retina holds considerable potential for establishing effective ocular biomarkers for FTD.

Automated summary

Frontotemporal dementia (FTD) is often misdiagnosed or diagnosed late due to clinical heterogeneity and overlap with other dementias. Optical coherence tomography (OCT) imaging of the retina shows promise in identifying ocular biomarkers for FTD, which could help improve research and patient care in the future.